The Technical Analyst
Select Language :
Avenue Therapeutics Inc [ATXI]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Avenue Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Avenue Therapeutics Inc is listed at the  Exchange

-3.34% $0.148

America/New_York / 28 mar 2024 @ 16:00


Avenue Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 6.53 mill
EPS: -0.980
P/E: -0.150
Earnings Date: May 09, 2024
SharesOutstanding: 44.26 mill
Avg Daily Volume: 5.45 mill
RATING 2024-03-28
A+
Strong Buy
RATINGS
Rating CashFlow: Buy
Return On Equity: Strong Buy
Return On Asset: Strong Buy
DE: Sell
P/E: Strong Buy
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debtn/an/an/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.150 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.03x
Company: PE -0.150 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.168
(14.13%) $0.0208
Date: 2024-03-29
Expected Trading Range (DAY)

$ 0.133 - 0.165

( +/- 10.72%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-01-02 Fortress Biotech, Inc. Buy 2 101 496 COMMON STOCK, PAR VALUE $0.0001
2023-12-11 Davidow Robert L Sell 264 000 Common Stock
2023-12-11 Davidow Robert L Sell 126 000 Common Stock
2023-12-11 Davidow Robert L Sell 128 000 Common Stock
2023-12-11 Davidow Robert L Sell 20 000 Common Stock
INSIDER POWER
69.55
Last 83 transactions
Buy: 6 354 200 | Sell: 1 021 576

Forecast: 16:00 - $0.150

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.150
Forecast 2: 16:00 - $0.150
Forecast 3: 16:00 - $0.150
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.148 (-3.34% )
Volume 0.791 mill
Avg. Vol. 5.45 mill
% of Avg. Vol 14.52 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Avenue Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Avenue Therapeutics Inc

RSI

Intraday RSI14 chart for Avenue Therapeutics Inc

Last 10 Buy & Sell Signals For ATXI

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Avenue Therapeutics Inc

ATXI

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.

Last 10 Buy Signals

Date Signal @
SFRXETHUSDMar 29 - 09:093 778.97
SISUSDMar 29 - 09:090.519
RDNTUSDMar 29 - 09:090.337
QTUMUSDMar 29 - 09:10$4.86
MUSEUSDMar 29 - 09:0818.74
OPUSDMar 29 - 09:103.65
MOVRUSDMar 29 - 09:10$22.22
PROMUSDMar 29 - 09:10$14.03
KDAUSDMar 29 - 09:09$1.440
OETHUSDMar 29 - 09:093 530.63

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.